1
|
Huang Y, Cai Y, Chen Y, Zhu Q, Feng W, Jin L, Ma Y. Cholelithiasis and cholecystectomy increase the risk of gastroesophageal reflux disease and Barrett's esophagus. Front Med (Lausanne) 2024; 11:1420462. [PMID: 39091288 PMCID: PMC11292949 DOI: 10.3389/fmed.2024.1420462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2024] [Accepted: 06/20/2024] [Indexed: 08/04/2024] Open
Abstract
Background Cholelithiasis or cholecystectomy may contribute to the development of gastroesophageal reflux disease (GERD), Barrett's esophagus (BE), and esophageal adenocarcinoma (EAC) through bile reflux; however, current observational studies yield inconsistent findings. We utilized a novel approach combining meta-analysis and Mendelian randomization (MR) analysis, to assess the association between them. Methods The literature search was done using PubMed, Web of Science, and Embase databases, up to 3 November 2023. A meta-analysis of observational studies assessing the correlations between cholelithiasis or cholecystectomy, and the risk factors for GERD, BE, and EACwas conducted. In addition, the MR analysis was employed to assess the causative impact of genetic pre-disposition for cholelithiasis or cholecystectomy on these esophageal diseases. Results The results of the meta-analysis indicated that cholelithiasis was significantly linked to an elevated risk in the incidence of BE (RR, 1.77; 95% CI, 1.37-2.29; p < 0.001) and cholecystectomy was a risk factor for GERD (RR, 1.37; 95%CI, 1.09-1.72; p = 0.008). We observed significant genetic associations between cholelithiasis and both GERD (OR, 1.06; 95% CI, 1.02-1.10; p < 0.001) and BE (OR, 1.21; 95% CI, 1.11-1.32; p < 0.001), and a correlation between cholecystectomy and both GERD (OR, 1.04; 95% CI, 1.02-1.06; p < 0.001) and BE (OR, 1.13; 95% CI, 1.06-1.19; p < 0.001). After adjusting for common risk factors, such as smoking, alcohol consumption, and BMI in multivariate analysis, the risk of GERD and BE still persisted. Conclusion Our study revealed that both cholelithiasis and cholecystectomy elevate the risk of GERD and BE. However, there is no observed increase in the risk of EAC, despite GERD and BE being the primary pathophysiological pathways leading to EAC. Therefore, patients with cholelithiasis and cholecystectomy should be vigilant regarding esophageal symptoms; however, invasive EAC cytology may not be necessary.
Collapse
Affiliation(s)
- Yu Huang
- Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| | - Yicong Cai
- Department of Gastrointestinal Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| | - Yingji Chen
- Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| | - Qianjun Zhu
- Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| | - Wei Feng
- Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| | - Longyu Jin
- Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| | - Yuchao Ma
- Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China
| |
Collapse
|
2
|
Ouyang Q, Xu Y, Ban Y, Li J, Cai Y, Wu B, Hao Y, Sun Z, Zhang M, Wang M, Wang W, Zhao Y. Probiotics and Prebiotics in Subclinical Hypothyroidism of Pregnancy with Small Intestinal Bacterial Overgrowth. Probiotics Antimicrob Proteins 2024; 16:579-588. [PMID: 37032411 PMCID: PMC10987341 DOI: 10.1007/s12602-023-10068-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/20/2023] [Indexed: 04/11/2023]
Abstract
Evaluating efficacy of probiotics combined with prebiotics in small intestinal bacterial overgrowth (SIBO) in subclinical hypothyroidism (SCH) in the second trimester. We collected data from 78 pregnant women with SCH (SCH group) and 74 normal pregnant women (control group) in second trimester, compare the differences in high sensitivity C-reactive protein (hsCRP), result of lactulose methane-hydrogen breath test and gastrointestinal symptoms assessed by GSRS scale between two groups. In SCH group, 32 patients with SIBO were selected as intervention group. Treatment with probiotics + prebiotics for 21 days; The differences of lipid metabolism, hsCRP, thyroid function level, methane-hydrogen breath test results and GSRS scores before and after treatment were compared to evaluate the therapeutic effect. (1) The positive rate of SIBO and methane, hsCRP levels in SCH group were higher than those in control group (P < 0.05), the total score of GSRS scale, mean score of indigestion syndrome, and constipation syndrome in SCH group were higher (P < 0.05). (2) The mean abundance of hydrogen and methane were higher in SCH group. (3) After treatment, serum levels of thyrotropin(TSH), total cholesterol(TC), triglyceride(TG), low-density lipoprotein (LDL), and hsCRP in intervention group were decreased, and high-density lipoprotein (HDL) was increased compared with before treatment (P < 0.05). (4) After treatment, methane positive rate, total score of GSRS scale, mean score of diarrhea syndrome, dyspepsia syndrome, and constipation syndrome were decreased (P < 0.05). (5) The average abundance of methane and hydrogen were lower. Probiotics combined with prebiotics are effective in the treatment of SIBO in pregnant SCH patients.Clinical Trial Registration Number: ChiCTR1900026326.
Collapse
Affiliation(s)
- Qian Ouyang
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Yajuan Xu
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
| | - Yanjie Ban
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Jingjing Li
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Yanjun Cai
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Bo Wu
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Yingqi Hao
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Zongzong Sun
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Miao Zhang
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Mengqi Wang
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Wentao Wang
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Yinkai Zhao
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
3
|
Romero RJ, Martinez-Mier G, Ayala-García MA, Beristain-Hernández JL, Chan-Nuñez LC, Chapa-Azuela O, Dominguez-Rosado I, Flores-Villalba E, Fuentes-Orozco C, García-Covarrubias L, González-Ojeda A, Herrera-Hernández MF, Martinez-Ordaz JL, Medina-Franco H, Mercado MA, Montalvo-Jave E, Nuño-Guzmán CM, Torices-Escalante E, Torres-Villalobos GM, Vilatoba-Chapa M, Zamora-Godinez J, Zapata-Chavira H, Zerrweck-Lopez C. Establishing consensus on the perioperative management of cholecystectomy in public hospitals: a Delphi study with an expert panel in Mexico. HPB (Oxford) 2021; 23:685-699. [PMID: 33071151 DOI: 10.1016/j.hpb.2020.09.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 05/16/2020] [Accepted: 09/25/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND Several guidelines have put forward recommendations about the perioperative process of cholecystectomy. Despite the recommendations, controversy remains concerning several topics, especially in low- and middle-income countries. The aim of this study was to develop uniform recommendations for perioperative practices in cholecystectomy in Mexico to standardize this process and save public health system resources. METHODS A modified Delphi method was used. An expert panel of 23 surgeons anonymously completed two rounds of responses to a 29-item questionnaire with 110 possible answers. The consensus was assessed using the percentage of responders agreeing on each question. RESULTS From the 29 questions, the study generated 27 recommendations based on 20 (69.0%) questions reaching consensus, one that was considered uncertain (3.4%), and six (20.7%) items that remained open questions. In two (6.9%) cases, no consensus was reached, and no recommendation could be made. CONCLUSIONS This study provides recommendations for the perioperative management of cholecystectomy in public hospitals in Mexico. As a guide for public institutions in low- and middle-income countries, the study identifies recommendations for perioperative tests and evaluations, perioperative decision making, postoperative interventions and institutional investment, that might ensure the safe practice of cholecystectomy and contribute to conserving resources.
Collapse
Affiliation(s)
- Rey Jesus Romero
- Department of Bariatric & Metabolic Surgery, Spanish Hospital of Veracruz, 16 de Septiembre 955 Col. Centro, 91700, Veracruz, Ver., Mexico.
| | - Gustavo Martinez-Mier
- Department of Hepato-Biliary Surgery & Transplantation, High Speciality Medical Unit 14, Mexican Institute of Social Security, Cuahutémoc Col. Formando Hogar, 91810, Veracruz, Ver., Mexico
| | - Marco A Ayala-García
- Department of Surgery & Research, General Hospital Zone 58, Mexican Institute of Social Security, Boulevard Jorge Vértiz Campero 1949 Col, San Miguel de Rentería, 37238, León, Gto., Mexico
| | - Jose Luis Beristain-Hernández
- Department of Hepato-Biliary Surgery, National Medical Center "Antonio Fraga Mouret, La Raza", Seris y Zaachila Col. La Raza, 02990, Mexico City, Mexico
| | - Luis Carlos Chan-Nuñez
- Department of Hepato-Biliary Surgery, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - Oscar Chapa-Azuela
- Department of Hepato-Pancreato-Biliary Surgery, General Hospital of Mexico "Dr. Eduardo Liceaga", Dr. Balmis 148 Col. Doctores, 06720, Mexico City, Mexico
| | - Ismael Dominguez-Rosado
- Department of Hepato-Biliary Surgery, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - Eduardo Flores-Villalba
- Department of Hepato-Biliary Surgery & Transplantation, Zambrano Hellion Medical Center Monterrey Institute of Technology and Higher Education, Batallón de San Patricio 112 Col. Real San Agustín, 66278, San Pedro Garza García, N.L., Mexico
| | - Clotilde Fuentes-Orozco
- Department of Surgery & Research, Western National Medical Center, Mexican Institute of Social Security, Belisario Dominguez 1000 Col. Belisario Dominguez, 44329, Guadalajara, Jal., Mexico
| | - Luis García-Covarrubias
- Department of Transplantation, General Hospital of Mexico "Dr. Eduardo Liceaga", Dr. Balmis 148 Col. Doctores, 06720, Mexico City, Mexico
| | - Alejandro González-Ojeda
- Department of Surgery & Research, Western National Medical Center, Mexican Institute of Social Security, Belisario Dominguez 1000 Col. Belisario Dominguez, 44329, Guadalajara, Jal., Mexico
| | - Miguel Francisco Herrera-Hernández
- Department of Endocrine Surgery, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - José Luis Martinez-Ordaz
- Department of Surgery, XXI Century National Medical Center, Mexican Institute of Social Security, Av. Cuahutémoc 33 Col. Doctores, 06720, Mexico City, Mexico
| | - Heriberto Medina-Franco
- Department of Surgical Oncology, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - Miguel Angel Mercado
- Department of Surgery, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - Eduardo Montalvo-Jave
- Department of Hepato-Pancreato-Biliary Surgery, General Hospital of Mexico "Dr. Eduardo Liceaga", Dr. Balmis 148 Col. Doctores, 06720, Mexico City, Mexico
| | - Carlos Martine Nuño-Guzmán
- Department of Surgery, Civil Hospital "Fray Antonio Alcalde", Hospital 278 Col. El Retiro, 44280, Guadalajara, Jal., Mexico
| | - Eduardo Torices-Escalante
- Department of Gastrointestinal Endoscopy, Regional Hospital October 1st, Institute for Social Security and Services for State Workers, Av. Politécnico Nacional 1669 Col. Magdalena de las Salinas, 07300, Mexico City, Mexico
| | - Gonzalo Manuel Torres-Villalobos
- Department of Experimental Surgery & Minimally Invasive Surgery, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - Mario Vilatoba-Chapa
- Department of Transplantation, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Vasco de Quiróga 15 Col. Belisario Dominguez, 14080, Mexico City, Mexico
| | - Jordán Zamora-Godinez
- Department of Surgery, General Hospital Zone 8, Mexican Institute of Social Security, Calle 18 de julio 214 Col. Periodistas, 42060, Pachuca, Hgo., Mexico
| | - Homero Zapata-Chavira
- Department of Surgery & Transplantation, University Hospital "Dr. José E. González", Av. Gonzalitos 235 Col. Mitras Centro, 64460, Monterrey, N.L., Mexico
| | - Carlos Zerrweck-Lopez
- Department of Bariatric & Metabolic Surgery, Tláhuac General Hospital, Av. La Turba 655 Col. Villa Centroamericana, 13250, Mexico City, Mexico
| |
Collapse
|
4
|
Zapf M, Denham W, Barrera E, Butt Z, Carbray J, Wang C, Linn J, Ujiki M. Patient-centered outcomes after laparoscopic cholecystectomy. Surg Endosc 2013; 27:4491-8. [PMID: 23943114 DOI: 10.1007/s00464-013-3095-0] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2013] [Accepted: 06/28/2013] [Indexed: 12/15/2022]
Abstract
BACKGROUND Laparoscopic cholecystectomy (LC) is the second most common general surgical operation performed in the United States, yet little has been reported on patient-centered outcomes. METHODS We prospectively followed 100 patients for 2 years as part of an institutional review board-approved study. The Surgical Outcomes Measurement System (SOMS) was used to quantify quality-of-life (QoL) values at various time points postoperatively. RESULTS Maximum pain was reported at 24 h (5.5 ± 2.2), and decreased to preoperative levels at 7 days (1.2 ± 2.3 vs. 2.0 ± 1.6, P = 0.096). Bowel function improved from before the operation to 3 weeks after surgery (10.7 ± 3.8 vs. 12.0 ± 3.2, P < 0.05), but then regressed to preoperative levels. Physical function worsened from before surgery (31.7 ± 6.2) to 1 week (27.5 ± 5.9, P < 0.0001), but surpassed preoperative levels at 3 weeks (33.5 ± 3.4, P < 0.01). Return to the activities of daily living occurred at 6.3 ± 4.7 days and work at 11.1 ± 9.0 days. Fatigue increased from before surgery (15.8 ± 6.2) to week 1 (20.7 ± 6.6, P < 0.0001) before improving at week 3 (14.0 ± 5.8, P < 0.01). Forty-four patients contacted the health care team 61 times before their 3 weeks appointment, most commonly for wound issues (26.2%), pain (24.6%), and gastrointestinal issues (24.6%). Seventy-two percent reported that the procedure had no negative effect on cosmesis at 6 months. Satisfaction with the procedure was high, averaging 9.52 out of 11. CONCLUSIONS QoL is significantly affected in the 24 h after LC but returns to baseline at week 3. Cosmesis and overall satisfaction are high, and QoL improvements are maintained in the long term except for bowel function, which regresses to preoperative levels of impairment. Analysis of patient-initiated contacts after LC may provide feedback on discharge counseling to increase patient satisfaction.
Collapse
Affiliation(s)
- Matthew Zapf
- Department of Surgery, Section of Minimally Invasive Surgery, NorthShore University HealthSystem, 2650 Ridge Ave, Evanston, IL, USA,
| | | | | | | | | | | | | | | |
Collapse
|